4-butyrolactone has been researched along with Anasarca in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsiao, HB; Hsieh, CC; Lin, H; Lin, WC; Wu, JB | 1 |
| Andriani, KF; Bastos, JK; Borges, A; Borges, CHG; Caramori, GF; Conforti, VA; Cunha, WR; da Silva Laurentiz, R; de Andrade, CQJ; E Silva, MLA; Januário, AH; Lima, TC; Lucarini, R; Parreira, RLT; Pauletti, PM; Símaro, GV; Souza, AMP; Volpe, AC | 1 |
| Ammar, S; Bouraoui, A; Chatter, R; Edziri, H; Mahjoub, MA; Mighri, Z | 1 |
| Choi, RJ; Chung, JW; Dong, MS; Guo, LY; Kim, YS; Nam, JW; Seo, EK; Shin, EM | 1 |
| Coppa, GF; Idrovo, JP; Nicastro, J; Wang, P; Yang, WL | 1 |
| Librowski, T; Malawska, B; Moniczewski, A; Salat, K; Stanisz-Wallis, K; Wieckowski, K | 1 |
| Ariki, Y; Hidaka, T; Hosoe, K; Katsumi, I; Kondo, H; Takeo, K; Watanabe, K; Yamashita, K; Yamashita, T | 1 |
| Alcaraz, MJ; De Rosa, M; Giordano, S; Pastor, PG; Payá, M; Scettri, A; Sodano, G; Soriente, A | 1 |
| Alcaraz, MJ; De Giulio, A; De Rosa, S; García Pastor, P; Payá, M | 1 |
| Fujimura, H; Hidaka, T; Hiramatsu, Y; Hosoe, K; Watanabe, K; Yamashita, T | 1 |
10 other study(ies) available for 4-butyrolactone and Anasarca
| Article | Year |
|---|---|
Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Collagen Type II; Cytokines; Disease Models, Animal; Edema; Inflammation Mediators; Knee Joint; Male; Mice, Inbred DBA; Monosaccharides; Orchidaceae; Phytotherapy; Plant Extracts; T-Lymphocytes | 2016 |
In vivo and in silico anti-inflammatory mechanism of action of the semisynthetic (-)-cubebin derivatives (-)-hinokinin and (-)-O-benzylcubebin.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzodioxoles; Catalytic Domain; Computer Simulation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyproheptadine; Dextrans; Dinoprostone; Dioxoles; Edema; Furans; Indomethacin; Ligands; Lignans; Male; Mice; Molecular Docking Simulation; Polysorbates; Rats, Wistar; Rutaceae | 2017 |
Spasmolytic and anti-inflammatory effects of constituents from Hertia cheirifolia.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Asteraceae; Carrageenan; Edema; Female; Male; Molecular Structure; Muscle, Smooth; Parasympatholytics; Phytotherapy; Plant Components, Aerial; Plant Extracts; Propylamines; Rats; Rats, Wistar; Sesquiterpenes; Stigmasterol | 2009 |
Anti-inflammatory effects of (Z)-ligustilide through suppression of mitogen-activated protein kinases and nuclear factor-κB activation pathways.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cell Culture Techniques; Cell Line; Cell Survival; Cyclooxygenase 2; Dose-Response Relationship, Drug; Down-Regulation; Edema; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; Molecular Structure; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2012 |
Stimulation of carnitine palmitoyltransferase 1 improves renal function and attenuates tissue damage after ischemia/reperfusion.
Topics: 4-Butyrolactone; Acute Kidney Injury; Adenosine Triphosphate; Animals; Carnitine O-Palmitoyltransferase; Edema; Energy Metabolism; Kidney; Leukocytes; Male; Peroxidase; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2012 |
Analgesic, antioedematous and antioxidant activity of γ-butyrolactone derivatives in rodents.
Topics: 4-Butyrolactone; Administration, Oral; Analgesics; Animals; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Free Radical Scavengers; Inflammation; Injections, Intraperitoneal; Male; Mice; Motor Activity; Pain; Rats; Rats, Wistar | 2012 |
Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Edema; Furans; Granuloma; Lipoxygenase Inhibitors; Male; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Stomach Ulcer | 1984 |
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bee Venoms; Carrageenan; Cell Line; Cytosol; Drug Design; Edema; Elapid Venoms; Enzyme Inhibitors; Female; Humans; Kinetics; Mice; Molecular Structure; Pancreas; Phospholipases A; Phospholipases A2; Pyrans; Structure-Activity Relationship; Swine; Synovial Membrane; Terpenes | 1998 |
Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.
Topics: 4-Butyrolactone; Acute Disease; Animals; Anti-Infective Agents; Arthritis, Experimental; Chronic Disease; Dose-Response Relationship, Drug; Ear; Edema; Enzymes; Female; Humans; Inflammation; Leukocytes; Male; Mice; Phospholipases A; Phospholipases A2; Pyrans; Rats; Rats, Wistar; Synovial Fluid; U937 Cells | 1999 |
Analgesic and anti-inflammatory activities in rats of alpha-(3,5-di-t-butyl-4-hydroxybenzylidene)-gamma-butyrolactone (KME-4), and its intestinal damage.
Topics: 4-Butyrolactone; Acetates; Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Capillary Permeability; Edema; Furans; Ibuprofen; Indomethacin; Intestinal Diseases; Lethal Dose 50; Male; Naproxen; Rats; Rats, Inbred Strains | 1986 |